55.17 USD
▼-1.69-2.96%
盘后 55.89 +1.31%
2026-09-15
市值
$155.66M
市盈率
—
EPS
-36.05
股息率
—
52 周区间
7.26 – 240.00
成交量
110.11K
Beta
3.36
目标价
147.88
52W 低 7.2652W 高 240.00
价格走势
公司简介
Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company develops TA-ERT, a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase, which is an enzyme replacement therapy for patients with Sanfilippo Syndrome Type B. It also develops Tildacerfont for treating a highly debilitating mental disorder characterized by depressed mood with cognitive-affective and somatic changes, including anhedonia, weight alterations, and altered sle...